{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:48Z","timestamp":1791566448675,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["22K08274"],"award-info":[{"award-number":["22K08274"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03379-3","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:57:46Z","timestamp":1761904666000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene variants of interferon induced with helicase C domain 1 in Japanese patients with Dermatomyositis-associated rapidly progressive interstitial lung disease: a genetic association study using whole-exome and Sanger sequencing"],"prefix":"10.1186","volume":"26","author":[{"given":"Masaki","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriho","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Gono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Kaieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kuwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"3379_CR1","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: A series of 107 patients. Arthritis Rheum. 2011;63:3439\u201347.","journal-title":"Arthritis Rheum"},{"key":"3379_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336.","journal-title":"J Am Acad Dermatol"},{"key":"3379_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jbspin.2006.04.005","volume":"73","author":"C Sordet","year":"2006","unstructured":"Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine. 2006;73:646\u201354.","journal-title":"Joint Bone Spine"},{"key":"3379_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11926-996-0025-3","volume":"8","author":"IN Targoff","year":"2006","unstructured":"Targoff IN. Myositis specific autoantibodies. Curr Rheumatol Rep. 2006;8:196\u2013203.","journal-title":"Curr Rheumatol Rep"},{"key":"3379_CR5","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20136.","journal-title":"Arthritis Rheum"},{"key":"3379_CR6","doi-asserted-by":"publisher","first-page":"2024869","DOI":"10.1155\/2020\/2024869","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Li Y, Wu J, Miao M, Gao X, Cai W, et al. Predictors of Poor Outcome of Anti-MDA5-Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis. J Immunol Res. 2020;2020:2024869.","journal-title":"J Immunol Res."},{"key":"3379_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/rheumatology\/key060","volume":"57","author":"S Sato","year":"2018","unstructured":"Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M, et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology (Oxford). 2018;57:1212\u201321.","journal-title":"Rheumatology (Oxford)"},{"key":"3379_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.resinv.2018.07.007","volume":"56","author":"S Sakamoto","year":"2018","unstructured":"Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, et al. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis. Respir Investig. 2018;56:464\u201372.","journal-title":"Respir Investig"},{"key":"3379_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2014.12.012","volume":"32","author":"M Yoneyama","year":"2015","unstructured":"Yoneyama M, Onomoto K, Jogi M, Akaboshi T, Fujita T. Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol. 2015;32:48\u201353.","journal-title":"Curr Opin Immunol"},{"key":"3379_CR10","doi-asserted-by":"publisher","first-page":"e001202","DOI":"10.1136\/rmdopen-2020-001202","volume":"6","author":"N Nishina","year":"2020","unstructured":"Nishina N, Sato S, Masui K, Gono T, Kuwana M. Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease. RMD Open. 2020;6:e001202.","journal-title":"RMD Open"},{"key":"3379_CR11","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/rheumatology\/kes102","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, Sato S, Kawaguchi Y, Kuwana M, Hanaoka M, Katsumata Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2012;51:1563\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"3379_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.immuni.2013.12.014","volume":"40","author":"M Funabiki","year":"2014","unstructured":"Funabiki M, Kato H, Miyachi Y, Toki H, Motegi H, Inoue M, et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity. 2014;40:199\u2013212.","journal-title":"Immunity"},{"key":"3379_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12931-023-02362-0","volume":"24","author":"Y Zaizen","year":"2023","unstructured":"Zaizen Y, Okamoto M, Azuma K, Fukuoka J, Hozumi H, Sakamoto N, et al. Enhanced immune complex formation in the lungs of patients with dermatomyositis. Respir Res. 2023;24:86.","journal-title":"Respir Res"},{"key":"3379_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41598-017-01685-5","volume":"7","author":"K Oda","year":"2017","unstructured":"Oda K, Kotani T, Takeuchi T, Ishida T, Shoda T, Isoda K, et al. Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study. Sci Rep. 2017;7:1635.","journal-title":"Sci Rep"},{"key":"3379_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1167728","volume":"324","author":"S Nejentsev","year":"2009","unstructured":"Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 2009;324:387\u20139.","journal-title":"Science"},{"key":"3379_CR16","doi-asserted-by":"publisher","first-page":"13348","DOI":"10.1074\/jbc.M809449200","volume":"284","author":"T Shigemoto","year":"2009","unstructured":"Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, Fujita T. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem. 2009;284:13348\u201354.","journal-title":"J Biol Chem"},{"key":"3379_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 2014;46:503\u20139.","journal-title":"Nat Genet"},{"key":"3379_CR18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.468","volume":"41","author":"V Gateva","year":"2009","unstructured":"Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009;41:1228\u201333.","journal-title":"Nat Genet"},{"key":"3379_CR19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.4049\/jimmunol.1100857","volume":"187","author":"T Robinson","year":"2011","unstructured":"Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-\u03b1 and serologic autoimmunity in lupus patients. J Immunol. 2011;187:1298\u2013303.","journal-title":"J Immunol"},{"key":"3379_CR20","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20161759","volume":"214","author":"IT Lamborn","year":"2017","unstructured":"Lamborn IT, Jing H, Zhang Y, Drutman SB, Abbott JK, Munir S, et al. Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J Exp Med. 2017;214:1949\u201372.","journal-title":"J Exp Med"},{"key":"3379_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"3379_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403\u20137.","journal-title":"N Engl J Med"},{"key":"3379_CR23","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, et al. Diagnosis of idiopathic pulmonary Fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44\u201368.","journal-title":"Am J Respir Crit Care Med"},{"key":"3379_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"3379_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1843.2009.01687.x","volume":"15","author":"Y Kondoh","year":"2010","unstructured":"Kondoh Y, Taniguchi H, Kataoka K, Kato K, Suzuki R, Ogura T, et al. Prognostic factors in rapidly progressive interstitial pneumonia. Respirology. 2010;15:257\u201364.","journal-title":"Respirology"},{"key":"3379_CR26","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"3379_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: A mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"3379_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"3379_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2017-212149","volume":"77","author":"Y Kochi","year":"2018","unstructured":"Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, et al. Splicing variant of WDFY4 augments MDA5 signaling and the risk of clinically amyopathic dermatomyositis. Ann Rheum Dis. 2018;77:602\u201311.","journal-title":"Ann Rheum Dis"},{"key":"3379_CR30","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/art.41105","volume":"72","author":"H Tsuji","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al. Multicenter prospective study of rapidly progressive interstitial lung disease with anti\u2013MDA5 antibody\u2013Positive dermatomyositis: an update on the efficacy of early intensive intervention with combined immunosuppressive therapy. Arthritis Rheumatol. 2020;72:1536\u201346.","journal-title":"Arthritis Rheumatol"},{"key":"3379_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Ros\u00e1rio","year":"2013","unstructured":"Ros\u00e1rio C, Zandman-Goddard G, Meyron-Holtz EG, D\u2019Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185.","journal-title":"BMC Med"},{"key":"3379_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50:3\u201313.","journal-title":"Respir Investig"},{"key":"3379_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13023-016-0430-2","volume":"11","author":"F Bonella","year":"2016","unstructured":"Bonella F, Long X, Ohshimo S, Horimasu Y, Griese M, Guzman J, et al. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2016;11:48.","journal-title":"Orphanet J Rare Dis"},{"key":"3379_CR34","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/nu16223793","volume":"16","author":"ES B\u00f6sch","year":"2024","unstructured":"B\u00f6sch ES, Sp\u00f6rri J, Scherr J. Genetic variants affecting iron metabolism in healthy adults: A systematic review to support personalized nutrition strategies. Nutrients. 2024;16:3793.","journal-title":"Nutrients"},{"key":"3379_CR35","doi-asserted-by":"publisher","first-page":"e0155381","DOI":"10.1371\/journal.pone.0155381","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Wu G, Gao D, Liu G, Pan L, Ni L, et al. Factors associated with interstitial lung disease in patients with polymyositis and dermatomyositis: A systematic review and Meta-Analysis. PLoS ONE. 2016;11:e0155381.","journal-title":"PLoS ONE"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03379-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:57:47Z","timestamp":1761904667000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3379"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03379-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Institutional Review Board of Kurume University School of Medicine and collaborative facilities in accordance with the ethical standards of the Helsinki Declaration of 2013 (approval numbers 355 (September 18, 2018) and 416 (November 16, 2020)). Written informed consent was obtained from patients in the prospective cohort study, and opt-out informed consent was obtained from patients in the retrospective pilot study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}